Common asthma med speeds up recovery in early COVID-19
Inhaled budesonide, a common corticosteroid for treating asthma, shortens recovery time compared with standard care in COVID-19 outpatients who are at high risk of severe illness, according to interim results of the PRINCIPLE* study.